Univ. not to patent chemical
Students call for partner company not to enforce license on new AIDS drug
Following Yale’s decision last week not to apply for a patent in low- and middle-income countries for chemical which may be used in anti-HIV drugs, students are calling on the University to pressure its business partner to refrain from enforcing its own license on the compound in those countries.
Students involved in the group Universities Allied for Essential Medicines want Oncolys BioPharma, a Tokyo pharmaceutical company, not to enforce its current license so that generic pharmaceutical companies would be able to cheaply produce and distribute drugs based on the chemical, called...
Sorry, but comments are disabled for this article.